Abstract P2-09-05: Germline <i>BRCA1/2</i> mutation testing in human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer (ABC): A real-world study in the Syapse Learning Health Network (LHN)

Authors: Alexander Niyazov, Monika Izano, Colden Johanson, Sheetal Walters, Anna Berry, Bhakti Arondekar, A. Douglas Laird, Lillian Shahied Arruda, Henry Kaplan

Published: 2022-03-08

DOI: 10.1158/1538-7445.sabcs21-p2-09-05

Source: Full article